143 related articles for article (PubMed ID: 22009278)
1. Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease.
Gochuico BR; Huizing M; Golas GA; Scher CD; Tsokos M; Denver SD; Frei-Jones MJ; Gahl WA
Mol Med; 2012 Feb; 18(1):56-64. PubMed ID: 22009278
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic and Ultrastructural Analysis of Mast Cells in Hermansky-Pudlak Syndrome Type-1: A Possible Connection to Pulmonary Fibrosis.
Kirshenbaum AS; Cruse G; Desai A; Bandara G; Leerkes M; Lee CC; Fischer ER; O'Brien KJ; Gochuico BR; Stone K; Gahl WA; Metcalfe DD
PLoS One; 2016; 11(7):e0159177. PubMed ID: 27459687
[TBL] [Abstract][Full Text] [Related]
3. Long-term nintedanib treatment for progressive pulmonary fibrosis associated with Hermansky-Pudlak syndrome type 1 followed by lung transplantation.
Itoh T; Kawasaki T; Kaiho T; Shikano K; Naito A; Abe M; Suzuki H; Ota M; Yoshino I; Suzuki T
Respir Investig; 2024 Jan; 62(1):176-178. PubMed ID: 38154291
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome.
Summer R; Krishna R; Schriner D; Cuevas-Mora K; Sales D; Para R; Roman J; Nieweld C; Gochuico BR; Romero F
Orphanet J Rare Dis; 2019 Jul; 14(1):162. PubMed ID: 31272455
[TBL] [Abstract][Full Text] [Related]
5. CB
Cinar R; Park JK; Zawatsky CN; Coffey NJ; Bodine SP; Abdalla J; Yokoyama T; Jourdan T; Jay L; Zuo MXG; O'Brien KJ; Huang J; Mackie K; Alimardanov A; Iyer MR; Gahl WA; Kunos G; Gochuico BR; Malicdan MCV
Clin Transl Med; 2021 Jul; 11(7):e471. PubMed ID: 34323400
[TBL] [Abstract][Full Text] [Related]
6. A family history of Hermansky-Pudlak syndrome complicated with pulmonary fibrosis: a case series and review.
Liendo Martinez K; Pedraza F; Fuentes Alonso M; Puente Maestu L; Rodriguez Naranjo C; De Miguel-Diez J
Respirol Case Rep; 2021 Apr; 9(4):e00720. PubMed ID: 33732463
[TBL] [Abstract][Full Text] [Related]
7. Hermansky-Pudlak syndrome protein complexes associate with phosphatidylinositol 4-kinase type II alpha in neuronal and non-neuronal cells.
Salazar G; Zlatic S; Craige B; Peden AA; Pohl J; Faundez V
J Biol Chem; 2009 Jan; 284(3):1790-802. PubMed ID: 19010779
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated alveolar epithelial cell progenitor function and identity in Hermansky-Pudlak syndrome pulmonary fibrosis.
Wang JY; Michki NS; Sitaraman S; Banaschewski BJ; Lin SM; Katzen JB; Basil MC; Cantu E; Zepp JA; Frank DB; Young LR
bioRxiv; 2024 Jun; ():. PubMed ID: 38496421
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis.
Padilha EC; Yang M; Shah P; Wang AQ; Duan J; Park JK; Zawatsky CN; Malicdan MCV; Kunos G; Iyer MR; Gaucher G; Ravenelle F; Cinar R; Xu X
Biomed Pharmacother; 2023 Dec; 168():115178. PubMed ID: 37890204
[TBL] [Abstract][Full Text] [Related]
10. Early ophthalmic findings in Hermansky-Pudlak syndrome type 9.
Sefau Y; Hodgson K; Robichaud J; Dahrab M
Can J Ophthalmol; 2024 Jun; 59(3):e267-e268. PubMed ID: 38431267
[No Abstract] [Full Text] [Related]
11. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients.
Lucas SEM; Raspin K; Mackintosh J; Glaspole I; Reynolds PN; Chia C; Grainge C; Kendall P; Troy L; Schwartz DA; Wood-Baker R; Walsh SLF; Moodley Y; Robertson J; Macansh S; Walters EH; Chambers D; Corte TJ; Dickinson JL
Pulmonology; 2023; 29(3):257-260. PubMed ID: 36216738
[No Abstract] [Full Text] [Related]
12. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
Mackintosh JA; Chambers DC
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237995
[No Abstract] [Full Text] [Related]
13. Leukocyte telomere length: the dawn of a new era of personalised medicine in fibrotic interstitial lung diseases?
Cottin V; Kolb M
Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 38035695
[No Abstract] [Full Text] [Related]
14. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.
Murray CJ; Atkinson C; Bhalla K; Birbeck G; Burstein R; Chou D; Dellavalle R; Danaei G; Ezzati M; Fahimi A; Flaxman D; Foreman ; Gabriel S; Gakidou E; Kassebaum N; Khatibzadeh S; Lim S; Lipshultz SE; London S; Lopez ; MacIntyre MF; Mokdad AH; Moran A; Moran AE; Mozaffarian D; Murphy T; Naghavi M; Pope C; Roberts T; Salomon J; Schwebel DC; Shahraz S; Sleet DA; Murray ; Abraham J; Ali MK; Atkinson C; Bartels DH; Bhalla K; Birbeck G; Burstein R; Chen H; Criqui MH; Dahodwala ; Jarlais ; Ding EL; Dorsey ER; Ebel BE; Ezzati M; Fahami ; Flaxman S; Flaxman AD; Gonzalez-Medina D; Grant B; Hagan H; Hoffman H; Kassebaum N; Khatibzadeh S; Leasher JL; Lin J; Lipshultz SE; Lozano R; Lu Y; Mallinger L; McDermott MM; Micha R; Miller TR; Mokdad AA; Mokdad AH; Mozaffarian D; Naghavi M; Narayan KM; Omer SB; Pelizzari PM; Phillips D; Ranganathan D; Rivara FP; Roberts T; Sampson U; Sanman E; Sapkota A; Schwebel DC; Sharaz S; Shivakoti R; Singh GM; Singh D; Tavakkoli M; Towbin JA; Wilkinson JD; Zabetian A; Murray ; Abraham J; Ali MK; Alvardo M; Atkinson C; Baddour LM; Benjamin EJ; Bhalla K; Birbeck G; Bolliger I; Burstein R; Carnahan E; Chou D; Chugh SS; Cohen A; Colson KE; Cooper LT; Couser W; Criqui MH; Dabhadkar KC; Dellavalle RP; Jarlais ; Dicker D; Dorsey ER; Duber H; Ebel BE; Engell RE; Ezzati M; Felson DT; Finucane MM; Flaxman S; Flaxman AD; Fleming T; Foreman ; Forouzanfar MH; Freedman G; Freeman MK; Gakidou E; Gillum RF; Gonzalez-Medina D; Gosselin R; Gutierrez HR; Hagan H; Havmoeller R; Hoffman H; Jacobsen KH; James SL; Jasrasaria R; Jayarman S; Johns N; Kassebaum N; Khatibzadeh S; Lan Q; Leasher JL; Lim S; Lipshultz SE; London S; Lopez ; Lozano R; Lu Y; Mallinger L; Meltzer M; Mensah GA; Michaud C; Miller TR; Mock C; Moffitt TE; Mokdad AA; Mokdad AH; Moran A; Naghavi M; Narayan KM; Nelson RG; Olives C; Omer SB; Ortblad K; Ostro B; Pelizzari PM; Phillips D; Raju M; Razavi H; Ritz B; Roberts T; Sacco RL; Salomon J; Sampson U; Schwebel DC; Shahraz S; Shibuya K; Silberberg D; Singh JA; Steenland K; Taylor JA; Thurston GD; Vavilala MS; Vos T; Wagner GR; Weinstock MA; Weisskopf MG; Wulf S; Murray ;
JAMA; 2013 Aug; 310(6):591-608. PubMed ID: 23842577
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.
Allen RJ; Porte J; Braybrooke R; Flores C; Fingerlin TE; Oldham JM; Guillen-Guio B; Ma SF; Okamoto T; John AE; Obeidat M; Yang IV; Henry A; Hubbard RB; Navaratnam V; Saini G; Thompson N; Booth HL; Hart SP; Hill MR; Hirani N; Maher TM; McAnulty RJ; Millar AB; Molyneaux PL; Parfrey H; Rassl DM; Whyte MKB; Fahy WA; Marshall RP; Oballa E; Bossé Y; Nickle DC; Sin DD; Timens W; Shrine N; Sayers I; Hall IP; Noth I; Schwartz DA; Tobin MD; Wain LV; Jenkins RG
Lancet Respir Med; 2017 Nov; 5(11):869-880. PubMed ID: 29066090
[TBL] [Abstract][Full Text] [Related]
16. Hermansky-Pudlak Syndrome.
El-Chemaly S; Young LR
Clin Chest Med; 2016 Sep; 37(3):505-11. PubMed ID: 27514596
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3- and phospho-caveolin-1-dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells.
Boscher C; Nabi IR
Mol Biol Cell; 2013 Jul; 24(13):2134-45. PubMed ID: 23657817
[TBL] [Abstract][Full Text] [Related]
18. Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis.
Cinar R; Basu A; Arif M; Park JK; Zawatsky CN; Zuo BLG; Zuo MXG; O'Brien KJ; Behan M; Introne W; Iyer MR; Gahl WA; Malicdan MCV; Gochuico BR
medRxiv; 2024 May; ():. PubMed ID: 38798603
[TBL] [Abstract][Full Text] [Related]
19. Evolutionary genetics of pulmonary anatomical adaptations in deep-diving cetaceans.
Guo B; Sun Y; Wang Y; Zhang Y; Zheng Y; Xu S; Yang G; Ren W
BMC Genomics; 2024 Apr; 25(1):339. PubMed ID: 38575860
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
